Recruiting
Pancreatic carcinoma+1
RecruitingStudy on PBP1510 and Gemcitabine for Patients with Advanced Pancreatic Cancer After Previous Chemotherapy
InvestigationalNo placebo
Study on PBP1510 and Gemcitabine for Patients with Advanced Pancreatic Cancer After Previous Chemotherapy
InvestigationalNo placebo
- Disease:Pancreatic carcinomaAdenocarcinoma pancreas
- Substances:Anti-(pancreatic adenocarcinoma upregulated factor) IgG1 humanised monoclonal antibody
Countries:
Spain
Spain- Participants:18–64 years · 65+ years
- Substances:Anti-(pancreatic adenocarcinoma upregulated factor) IgG1 humanised monoclonal antibody
